moxifloxacin has been researched along with Herpes Zoster, Ocular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, SK; Goel, I; Jha, UP; Nayyar, S; Rehman, O | 1 |
| Chen, A; Jabbour, S; Shekhawat, NS; Woreta, FA | 1 |
2 other study(ies) available for moxifloxacin and Herpes Zoster, Ocular
| Article | Year |
|---|---|
Herpes Zoster Ophthalmicus After COVID-19 Vaccination: Chance Occurrence or More?
Topics: Acyclovir; Administration, Ophthalmic; Administration, Oral; Adult; Anti-Bacterial Agents; Antiviral Agents; ChAdOx1 nCoV-19; Conjunctivitis, Viral; COVID-19; Drug Therapy, Combination; Herpes Zoster Ophthalmicus; Humans; Male; Moxifloxacin; SARS-CoV-2; Vaccination; Valacyclovir; Visual Acuity | 2022 |
Presumed Herpes Zoster Ophthalmicus Reactivation Following Recombinant Zoster Vaccination.
Topics: Aged; Anti-Bacterial Agents; Antiviral Agents; Drug Therapy, Combination; Erythromycin; Eye Infections, Viral; Female; Herpes Zoster Ophthalmicus; Herpes Zoster Vaccine; Herpesvirus 3, Human; Humans; Immunization, Secondary; Latent Infection; Moxifloxacin; Vaccination; Valacyclovir; Virus Activation; Visual Acuity | 2021 |